San Francisco, United States
SamaCare is revolutionizing the healthcare administrative process with its Script-to-Therapy platform, addressing a critical pain point in patient access to specialty medications. Founded in 2018 in the United States, the company devises solutions that significantly streamline the onerous task of prior authorization.
Their cloud-based system digitally transforms the antiquated, manual paper processes involved in approval and documentation, simplifying it for medical practices. This innovation is key to alleviating the administrative burden that can impede patient care while simultaneously driving down associated costs.
SamaCare recently secured a $17.00M Series B investment in May 2024, led by investors including Questa Capital, South Park Commons, and Vive Collective. This funding indicates strong confidence from investors and positions the company for further growth and market expansion in the healthcare technology sector.
ModMed